Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Free Cash Flow (2020 - 2026)

Climb Bio filings provide 7 years of Free Cash Flow readings, the most recent being -$14.4 million for Q1 2026.

  • Quarterly Free Cash Flow rose 6.84% to -$14.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$53.4 million through Mar 2026, down 83.06% year-over-year, with the annual reading at -$54.5 million for FY2025, 250.48% down from the prior year.
  • Free Cash Flow hit -$14.4 million in Q1 2026 for Climb Bio, up from -$15.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $3.5 million in Q3 2023 and bottomed at -$15.6 million in Q4 2025.
  • Average Free Cash Flow over 5 years is -$8.4 million, with a median of -$8.4 million recorded in 2022.
  • The largest annual shift saw Free Cash Flow surged 183.59% in 2023 before it tumbled 1571.36% in 2025.
  • Climb Bio's Free Cash Flow stood at -$8.4 million in 2022, then surged by 88.79% to -$947000.0 in 2023, then tumbled by 483.0% to -$5.5 million in 2024, then plummeted by 183.19% to -$15.6 million in 2025, then rose by 8.03% to -$14.4 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Free Cash Flow are -$14.4 million (Q1 2026), -$15.6 million (Q4 2025), and -$12.2 million (Q3 2025).